Infectious Disease Diagnostics Market by Product (Assays and Kits, Instruments, and Software and Services), Technology (Immunodiagnostics, NGS, PCR), Disease Type (Hepatitis, HIV, HPV, Tuberculosis), End User, and Geography - Global Forecast to 2025

  • Report ID:MRHC - 104274
  • Pages: 167
  • May 2019
  • Formats*: PDF
  • Category: Healthcare

1. Introduction
    1.1. Market Definition
    1.2. Market Ecosystem
    1.3. Currency and Limitations
           1.3.1. Currency
           1.3.2. Limitations
    1.4. Key Stakeholders

2. Research Methodology
    2.1. Research Process
           2.1.1. Secondary Research
           2.1.2. Primary Research
           2.1.3. Market Size Estimation

3. Executive Summary
    3.1. Introduction
    3.2. Market Dynamics
    3.3. Product Segment Analysis
    3.4. Technology Segment Analysis
    3.5. Disease Type Segment Analysis
    3.6. End User Segment Analysis
    3.7. Regional Analysis
    3.8. Competitive Analysis

4. Market insights
    4.1. Market Overview
    4.2. Drivers
           4.2.1. Increasing Global Prevalence of Infectious Diseases
           4.2.2. Growing Awareness for Early Detection Using Specific Diagnostic Tests
           4.2.3. Growth in Funding for Research on Infectious Disease Diagnostics
           4.2.4. Shift in Focus from Centralized Laboratories to Decentralized Point-Of-Care Testing
    4.3. Restraints
           4.3.1. Unfavorable and inadequate Reimbursement Scenario
    4.4. Challenges
           4.4.1. Lack of Awareness of Specific Symptoms and Diagnosis of Emerging infections
    4.5. Opportunities
           4.5.1. Advances in Genomics and Proteomics
           4.5.2. Growing Awareness about Personalized Medicines
           4.5.3. Growth Opportunities in Emerging Economies

5. Global Infectious Disease Diagnostics Market, by Product and Services
    5.1. Introduction
    5.2. Assays and Kits
    5.3. Instruments
    5.4. Software and Services

6. Global Infectious Disease Diagnostics Market, by Technology
    6.1. Introduction
    6.2. Immunodiagnostics
    6.3. Clinical Microbiology
    6.4. Polymerase Chain Reaction (PCR)
    6.5. Isothermal Nucleic Acid Amplification Technology (INAAT)
    6.6. DNA Sequencing & Next-Generation Sequencing (NGS)
    6.7. DNA Microarray
    6.8. Other Technologies

7. Global Infectious Disease Diagnostics Market, by Disease Type
    7.1. Introduction
    7.2. Hepatitis
    7.3. HIV
    7.4. Hospital-Acquired infections (HAIS)
    7.5. Human Papillomavirus (HPV)
    7.6. Tuberculosis (TB)
    7.7. Influenza
    7.8. Other Infectious Diseases

8. Global Infectious Disease Diagnostics Market, by End User
    8.1. Introduction
    8.2. Hospital/Clinical Laboratories
    8.3. Reference Laboratories
    8.4. Academics/Research institutes
    8.5. Other End Users

9. Infectious Disease Diagnostics Market, by Region
    9.1. Introduction
    9.2. North America
           9.2.1. U.S.
           9.2.2. Canada
    9.3. Europe
           9.3.1. Germany
           9.3.2. U.K.
           9.3.3. France
           9.3.4. Rest of Europe (RoE)
    9.4. Asia Pacific
           9.4.1. China
           9.4.2. Japan
           9.4.3. Rest of Asia Pacific (ROAPAC)
    9.5. Latin America
    9.6. Middle East and Africa

10. Competitive Landscape
      10.1. Overview
      10.2. Inorganic Growth Strategies
               10.2.1. Agreements, Collaborations, and Partnerships
               10.2.2. Acquisitions
      10.3. Organic Growth Strategies
               10.3.1. Product and Service Launches
      10.4. Market Positioning/Ranking
      10.5. Performance of the Key Players
               10.5.1. F. Hoffmann-La Roche Ltd
               10.5.2. Abbott Laboratories
               10.5.3. Danaher Corporation
               10.5.4. BD

11. Company Profiles (Includes Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
      11.1. Abbott Laboratories
      11.2. Danaher
      11.3. Bio-Rad Laboratories, Inc.
      11.4. bioMérieux
      11.5. F. Hoffmann-La Roche Ltd
      11.6. BD (Becton, Dickinson and Company)
      11.7. DiaSorin S.P.A.
      11.8. Meridian Bioscience, Inc.
      11.9. Quidel Corporation
      11.10. Thermo Fisher Scientific Inc.

12. Appendix
      12.1. Questionnaire
      12.2. Available Customization

List of Tables
Table 1 Clinical Applications of Infectious Disease Genomics and Proteomics
Table 2 Assays and Kits Market Size, by Country/ Region, 2016–2025 ($Million)
Table 3 Instruments Market Size, by Country/Region, 2016–2025 ($Million)
Table 4 Software and Services Market Size, by Country/Region, 2016–2025 ($Million)
Table 5 Immunodiagnostics Market Size, by Country/Region, 2016–2025 ($Million)
Table 6 Clinical Microbiology Market Size, by Country/Region, 2016–2025 ($Million)
Table 7 Polymerase Chain Reaction (PCR) Market Size, by Country/Region, 2016–2025 ($Million)
Table 8 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size, by Country/Region, 2016–2025 ($Million)
Table 9 DNA Sequencing & Next-Generation Sequencing (NGS) Market Size, by Country/Region, 2016–2025 ($Million)
Table 10 DNA Microarray Market Size, by Country/Region, 2016–2025 ($Million) 46
Table 11 Other Technologies Market Size, by Country/Region, 2016–2025 ($Million)
Table 12 Hepatitis Disease Diagnostics Market Size, by Country/Region, 2016–2025 ($Million)
Table 13 HIV Disease Diagnostics Market Size, by Country/Region, 2016–2025 ($Million)
Table 14 Hospital-Acquired infections Disease Diagnostics Market Size, by Country/Region, 2016–2025 ($Million)
Table 15 Human Papillomavirus (HPV) Disease Diagnostics Market Size, by Country/Region, 2016–2025 ($Million)
Table 16 Tuberculosis Disease Diagnostics Market Size, by Country/Region, 2016–2025 ($Million)
Table 17 Influenza Disease Diagnostics Market Size, by Country/Region, 2016–2025 ($Million)
Table 18 Other Infectious Diseases Diagnostics Market Size, by Country/Region, 2016–2025 ($Million)
Table 19 Infectious Disease Diagnostics Market Size for Hospital/Clinical Laboratories, by Country/Region 2016–2025 ($Million)
Table 20 Infectious Disease Diagnostics Market Size for Reference Laboratories, by Country/Region, 2016–2025 ($Million)
Table 21 Infectious Disease Diagnostics Market Size for Academics/Research institutes, by Country/Region, 2016–2025 ($Million)
Table 22 Infectious Disease Diagnostics Market Size for Other End User, by Country/Region, 2016–2025, ($Million)
Table 23 North America: Infectious Disease Diagnostics Market Size, by Country, 2016–2025 ($Million)
Table 24 North America: Infectious Disease Diagnostics Market Size, by Product and Services, 2016–2025 ($Million)
Table 25 North America: Infectious Disease Diagnostics Market Size, by Technology, 2016–2025 ($Million)
Table 26 North America: Infectious Disease Diagnostics Market Size, by Disease Type, 2016–2025 ($Million)
Table 27 North America: Infectious Disease Diagnostics Market Size, by End User, 2016–2025 ($Million)
Table 28 U.S.: Disease Rates and Number of New Cases (2015 & 2016)
Table 29 U.S.: Infectious Disease Diagnostics Market Size, by Product and Services, 2016–2025 ($Million)
Table 30 U.S.: Infectious Disease Diagnostics Market Size, by Technology, 2016–2025 ($Million)
Table 31 U.S.: Infectious Disease Diagnostics Market Size, by Disease Type, 2016–2025 ($Million)
Table 32 U.S.: Infectious Disease Diagnostics Market Size, by End User, 2016–2025 ($Million)
Table 33 Canada: Infectious Disease Diagnostics Market Size, by Product and Services, 2016–2025 ($Million)
Table 34 Canada: Infectious Disease Diagnostics Market Size, by Technology, 2016–2025 ($Million)
Table 35 Canada: Infectious Disease Diagnostics Market Size, by Disease Type, 2016–2025 ($Million)
Table 36 Canada: Infectious Disease Diagnostics Market Size, by End User, 2016–2025 ($Million)
Table 37 Europe: Infectious Disease Diagnostics Market Size, by Country, 2016–2025 ($Million)
Table 38 Europe: Infectious Disease Diagnostics Market Size, by Product and Services, 2016–2025 ($Million)
Table 39 Europe: Infectious Disease Diagnostics Market Size, by Technology, 2016–2025 ($Million)
Table 40 Europe: Infectious Disease Diagnostics Market Size, by Disease Type, 2016–2025 ($Million)
Table 41 Europe: Infectious Disease Diagnostics Market Size, by End User, 2016–2025 ($Million)
Table 42 Germany: Infectious Disease Diagnostics Market Size, by Product and Services, 2016–2025 ($Million)
Table 43 Germany: Infectious Disease Diagnostics Market Size, by Technology, 2016–2025 ($Million)
Table 44 Germany: Infectious Disease Diagnostics Market Size, by Disease Type, 2016–2025 ($Million)
Table 45 Germany: Infectious Disease Diagnostics Market Size, by End User, 2016–2025 ($Million)
Table 46 U.K. Infectious Disease Diagnostics Market Size, by Product and Services, 2016–2025 ($Million)
Table 47 U.K. Infectious Disease Diagnostics Market Size, by Technology, 2016–2025 ($Million)
Table 48 U.K. Infectious Disease Diagnostics Market Size, by Disease Type, 2016–2025 ($Million)
Table 49 U.K. Infectious Disease Diagnostics Market, by End User, 2016–2025 ($Million)
Table 50 France: Infectious Disease Diagnostics Market Size, by Product and Services, 2016–2025 ($Million)
Table 51 France: Infectious Disease Diagnostics Market Size, by Technology, 2016–2025 ($Million)
Table 52 France: Infectious Disease Diagnostics Market Size, by Disease Type, 2016–2025 ($Million)
Table 53 France: Infectious Disease Diagnostics Market, by End User, 2016–2025 ($Million)
Table 54 Hepatitis A Cases in 2016 and 2017
Table 55 Rest of Europe (RoE): Infectious Disease Diagnostics Market Size, by Product and Services, 2016–2025 ($Million)
Table 56 Rest of Europe (RoE): Infectious Disease Diagnostics Market Size, by Technology, 2016–2025 ($Million)
Table 57 Rest of Europe (RoE): Infectious Disease Diagnostics Market Size, by Disease Type, 2016–2025 ($Million)
Table 58 Rest of Europe (RoE): Infectious Disease Diagnostics Market Size, by End User, 2016–2025 ($Million)
Table 59 Asia Pacific: Infectious Disease Diagnostics Market Size, by Country, 2016–2025 ($Million)
Table 60 Asia Pacific: Infectious Disease Diagnostics Market Size, by Product and Services, 2016–2025 ($Million)
Table 61 Asia Pacific: Infectious Disease Diagnostics Market Size, by Technology, 2016–2025 ($Million)
Table 62 Asia Pacific: Infectious Disease Diagnostics Market Size, by Disease Type, 2016–2025 ($Million)
Table 63 Asia Pacific: Infectious Disease Diagnostics Market Size, by End User, 2016–2025 ($Million)
Table 64 China: Infectious Disease Diagnostics Market Size, by Product and Services, 2016–2025 ($Million)
Table 65 China: Infectious Disease Diagnostics Market Size, by Technology, 2016–2025 ($Million)
Table 66 China: Infectious Disease Diagnostics Market Size, by Disease Type, 2016–2025 ($Million)
Table 67 China: Infectious Disease Diagnostics Market Size, by End User, 2016–2025 ($Million)
Table 68 Japan: Infectious Disease Diagnostics Market Size, by Product and Services, 2016–2025 ($Million)
Table 69 Japan: Infectious Disease Diagnostics Market Size, by Technology, 2016–2025 ($Million)
Table 70 Japan: Infectious Disease Diagnostics Market Size, by Disease Type, 2016–2025 ($Million)
Table 71 Japan: Infectious Disease Diagnostics Market Size, by End User, 2016–2025 ($Million)
Table 72 RoAPAC: Infectious Disease Diagnostics Market Size, by Product and Services, 2016–2025 ($Million)
Table 73 RoAPAC: Infectious Disease Diagnostics Market Size, by Technology, 2016–2025 ($Million)
Table 74 RoAPAC: Infectious Disease Diagnostics Market Size, by Disease Type, 2016–2025 ($Million)
Table 75 RoAPAC: Infectious Disease Diagnostics Market Size, by End User, 2016–2025 ($Million)
Table 76 Latin America: Infectious Disease Diagnostics Market Size, by Country, 2016–2025 ($Million)
Table 77 Latin America: Infectious Disease Diagnostics Market Size, by Product and Services, 2016–2025 ($Million)
Table 78 Latin America: Infectious Disease Diagnostics Market Size, by Technology, 2016–2025 ($Million)
Table 79 Latin America: Infectious Disease Diagnostics Market Size, by Disease Type, 2016–2025 ($Million)
Table 80 Latin America: Infectious Disease Diagnostics Market Size, by End User, 2016–2025 ($Million)
Table 81 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Country, 2016–2025 ($Million)
Table 82 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Product and Services, 2016–2025 ($Million)
Table 83 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Technology, 2016–2025 ($Million)
Table 84 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Disease Type, 2016–2025 ($Million)
Table 85 Middle East & Africa: Infectious Disease Diagnostics Market Size, by End User, 2016–2025 ($Million)
Table 86 Meridian Bioscience, Inc.: Financial Overview (2016-2018)

List of Figures
Figure 1 Key Stakeholders in the Infectious Disease Diagnostics Market
Figure 2 Key Executives interviewed
Figure 3 Primary Research Techniques
Figure 4 Market Size Estimation
Figure 5 Global Infectious Disease Diagnostics Market, 2016–2025 ($ Million)
Figure 6 Infectious Disease Diagnostics Product: Global Market Outlook, 2018 VS. 2025
Figure 7 Infectious Disease Diagnostics Technology: Global Market Outlook, 2018 VS. 2025
Figure 8 Infectious Disease Diagnostics Disease Type: Global Market Outlook, 2018 VS. 2025
Figure 9 Infectious Disease Diagnostics End User: Global Market Outlook, 2018 VS. 2025
Figure 10 Infectious Disease Diagnostics: Regional Market Outlook, 2018 VS. 2025
Figure 11 Market Dynamics
Figure 12 Infectious Disease Diagnostics Market Size, by Product and Services, 2018–2025 ($Million)
Figure 13 Global Infectious Disease Diagnostics Market Size, by Technology, 2018–2025 ($Million)
Figure 14 Global Infectious Disease Diagnostics Market Size, by Disease Type, 2018–2025 ($Million)
Figure 15 Global Infectious Disease Diagnostics Market Size, by End User, 2018–2025 ($Million)
Figure 16 North America: Infectious Disease Diagnostics Market Size, by Country, 2018–2025 ($Million)
Figure 17 Europe: Infectious Disease Diagnostics Market Size, by Country, 2018–2025 ($Million)
Figure 18 Asia Pacific: Infectious Disease Diagnostics Market Size, by Country, 2018–2025 ($Million)
Figure 19 Latin America: Infectious Disease Diagnostics Market Size, by Country, 2018–2025 ($Million)
Figure 20 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Country, 2018–2025 ($Million)
Figure 21 Growth Strategies of the Prominent Players
Figure 22 Agreements, Collaborations, and Partnerships
Figure 23 Acquisitions
Figure 24 Product and Service Launches
Figure 25 Key Companies: Market Positioning/Ranking
Figure 26 Abbott Laboratories: Financial Overview (2016-2018)
Figure 27 Danaher: Financial Overview (2016-2018)
Figure 28 Bio-Rad Laboratories, Inc.: Financial Overview (2016-2018)
Figure 29 bioMérieux: Financial Overview (2016-2018)
Figure 30 F. Hoffmann-La Roche Ltd: Financial Overview (2016-2018)
Figure 31 BD (Becton, Dickinson and Company): Financial Overview (2016-2018)
Figure 32 DiaSorin S.P.A.: Financial Overview (2016-2018)
Figure 33 Quidel Corporation: Financial Overview (2016-2018)
Figure 34 Thermo Fisher Scientific Inc.: Financial Overview (2016-2018)

The global infectious disease diagnostics market is expected to grow at a CAGR of 5.9% from 2018 to 2025 to reach $12.88 billion by 2025. Infectious disease diagnostic procedures are designed to diagnose and investigate the causative agent of an infectious disease. The diagnosis of the infectious diseases is majorly based on clinical presentation or more rigorous diagnostic tests. Increasing global prevalence of infectious diseases, growing awareness for early detection using specific diagnostic tests, growth in funding for research on infectious disease diagnostics, and shift in focus from centralized laboratories to decentralized point-of-care testing are the major factors driving the growth of the infectious disease diagnostics market.

Increasing Global Prevalence of Infectious Diseases Fuels the Growth of the Global Infectious Disease Diagnostics Market

The epidemiological burden of sepsis across the globe has increased in the past few years. According to the World Health Organization (WHO), it was estimated to affect more than 30 million people every year across the globe, which leads to 6 million deaths. The burden of sepsis is most likely highest in low and middle-income countries.

According to WHO, 71 million of people were living with Hepatitis C (HCV) infection across the globe in 2017. A significant number of those who are chronically infected develop cirrhosis or liver cancer. Approximately, 399,000 people die every year from HCV, majorly from cirrhosis and hepatocellular carcinoma. Moreover, according to UNAIDS (The Joint United Nations Programme on HIV/AIDS), 36.9 million of people were living with HIV and 940,000 people died from AIDS-related illnesses in 2017 across the globe. According to WHO, in 2016, there were 2016 million estimated malaria cases occurred in 91 countries. The WHO African region carries a high burden for malaria among the population. In 2016, this region was home to 90% of malaria cases and 91% of malaria deaths. The increasing prevalence of infectious diseases across the globe significantly increases the demand for the diagnosis of these diseases for the early detection and prevention. The increasing demand of the diagnosis of these diseases is going to drive the growth of this market.

Significant Growth Opportunities in Emerging Countries Supports the  Infectious disease diagnostics Market Growth

Infectious disease diagnostics market with the incorporation of various advanced technologies has significantly increased their demand in the healthcare industry across the globe. The infectious disease diagnostics is poised for a significant growth over the years, primarily owing to its capability of taking the patient preventive health management to the next level. It will also facilitate the healthcare organizations to identify and detect the infectious diseases in the patient population in a cost-effective manner. Other than the developed countries, emerging countries are also focusing on incorporating adoption of various advanced technologies in the healthcare system for the identification and investigation of the infectious diseases to avoid the toll of life due to the life-threatening infectious diseases. Many of these developing economies are increasingly looking for technologies to address the increasing demand for point-of-care testing to save the life of the patient and at the same time contain the cost of delivery. This has led to increasing focus of healthcare industry in such economies to explore and exploit potential of the products used for the diagnosis of infectious diseases. With this, a number of providers of products for infectious disease diagnostics are also increasingly focusing on strengthening their presence in the developing economies. Several companies are also investing in the development of various software technologies to integrate with the diagnostic instruments in order to receive results with high precision and accuracy required for effective patient care.

The increasing healthcare expenditure in the emerging economies such as Asia Pacific and South and Central America are enabling the physicians to diagnose a wide range of infectious diseases through advanced testing and examination techniques. The emerging markets in the developing countries are offering better opportunities for the major players to expand their business. Most of the prominent market players are focusing on emerging economies such as Asia Pacific due to an increase in the prevalence of infectious diseases. The rising emerging nations such as India and China are expected to provide significant growth opportunities to the players operating in the market during the forecast period.

Advances in Genomics and Proteomics is Influencing Infectious disease diagnostics Market Growth

Proteomics and genomics are the powerful tools for studying the infectious diseases. During the last decades, the omic approaches have become an effective and crucial tool in the clinical research for the biological pathways involved in pathogen replication, host response, and disease progression. Genomics and proteomics became a major driver in the discovery and understanding of the interaction of host-pathogen. Genomic and proteomic information offers the opportunity for more personalized treatment and prevention.

Genomics primarily aims to sequence, assemble, and analyze the function and structure of genomes while proteomics helps in the large-scale study of the complete set of proteins within an organism. These tools are majorly designed for the discovery of novel molecular targets suitable for point-of-care (POC) diagnostics; improved design of vaccines and drugs with improved immunogenicity; and the genetic background of the population to be treated.

Advances in genomics and proteomics are primarily contributing to the development of effective, efficient, and personalized approaches for the prevention and treatment of infectious diseases. Advancement in the proteomics and genomics technology enables to understand the protein or genetic factors associated to trace the pattern of transmission and the origin of its outbreak. The advanced technology helps to speed up and simplify the process of diagnosis. Technical advancement in PCR technology, Nucleic Acid Amplification Testing (NAAT), microarray sequencing, and ELISA are majorly utilized for the diagnosis and treatment of infectious diseases.

Infectious Disease Diagnostics MarketClick Here: To Get Your Free Sample Report Now

Key Findings in the Global Infectious Disease Diagnostics Market Study:

Assays and Kits Dominates Global Infectious Disease Diagnostics Market

The assays and kits segment held the major market share in 2018. The highest share of the segment is primarily attributed to the increasing prevalence of infectious diseases, rising awareness among the population to identify the diseases, and increasing use of kits and reagents to identify the organism causing various diseases in lesser time and cost.

Polymerase Chain Reaction(PCR) to Witness Largest Demand Through 2025

The Polymerase Chain Reaction (PCR) segment is expected to grow with a highest CAGR in the global infectious disease diagnostics market. This is owing to certain factors such as increasing adoption of the molecular diagnostic technology in place of antigen testing by immunoassays; increasing chances of detecting minute amount of protein biomarkers with high specificity; and increasing probability of detecting infectious diseases to mitigate the result with high accuracy.

Hepatitis Segment Dominates the market in 2018

Hepatitis segment held the largest share of the infectious disease diagnostics market. This is mainly attributed to the increasing prevalence of hepatitis B & C infection, rising susceptibility of the geriatric population, growing awareness among the population, and increasing availability of various molecular diagnostic technologies.

Hospital/Clinical Laboratories Segment Dominates the market in 2018

The hospital/clinical laboratories segment held the major share in 2018. This is primarily attributed to the increasing number of outpatients for infectious diseases, increasing hospital expenditures, growing technological advancements for diagnostic platforms in hospitals, and increasing number of skilled professionals.

North America is the Largest and Asia Pacific the Fastest Growing Regional Market

North America commanded the largest share of the global infectious disease diagnostics market in 2018, followed by Europe and Asia Pacific. The highest share of North American region in the infectious disease diagnostics market is primarily attributed to the factors such as growing healthcare sector, increasing need to treat various infectious diseases, increasing healthcare expenditure, growing demand of point-of-care testing, increase in the research and development coupled with the development of novel advanced technologies for diagnosis, and large number of patient population.

Asia Pacific region is expected to be the fastest growing geographic market for infectious disease diagnostics with countries, such as China, Japan, India and Singapore among others are being the largest contributors to the growth of this market. Additionally, rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage growing burden of infectious diseases, and government efforts to improve accessibility of diagnostic services are expected to equally influence the overall growth of the infectious disease diagnostics market during the forecast period.

Disease Diagnostics Market Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2016-2019). The key players profiled in the global infectious disease diagnostics market research report are Abbott Laboratories (US), Danaher (US), Bio-Rad Laboratories (US), bioMérieux SA (France), F. Hoffmann-La Roche Ltd (Switzerland), BD (US), DiaSorin S.p.A. (Italy), Meridian Bioscience, Inc. (US), Quidel Corporation (US), and Thermo Fisher Scientific Inc. (US) among others.

Scope of Disease Diagnostics Market Report:

Infectious Disease Diagnostics Market, by Product

  • Assays and Kits
  • Instruments
  • Software & Services

Infectious Disease Diagnostics Market, by Technology

  • Immunodiagnostics
  • Clinical Microbiology
  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • DNA Sequencing & Next-Generation Sequencing (NGS)
  • DNA Microarray
  • Other Technologies

Infectious Disease Diagnostics Market, by Disease Type

  • Hepatitis
  • HIV
  • Hospital-Acquired Infections
  • HPV
  • Tuberculosis
  • Influenza
  • Other Infectious Diseases

Infectious Disease Diagnostics Market, by End User

  • Hospital/Clinical laboratories
  • Reference Laboratories
  • Academics/Research Institutes
  • Other End User

Infectious Disease Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe
  • Asia-Pacific (APAC)
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
  • Middle East and Africa

Key questions answered in Disease Diagnostics Market report:

Growing penetration of assay and kits in developing countries will propel the overall infectious disease diagnostics market

  • How does the penetration of infectious disease diagnostics products in developed regions differ from developing countries like India, and China?
  • How is the competition between the major global and prominent local players in this market?
  • Which are the high growth market segments in terms of product, technology, disease type, end users, regions, and countries?

Hospital/Clinical Laboratories account for the largest share of the infectious disease diagnostics market, globally

  • What factors contribute to the infrequent usage of overall infectious disease diagnostics in reference laboratories?
  • Which geographic segment is expected to experience the fastest growth in the usage of infectious disease diagnostics in hospitals/clinical laboratories?
  • How does the penetration of infectious disease diagnostics differ from other end users such as academic/research institutes?

Infectious disease diagnostics market favors both larger and local manufacturers that compete in multiple segments

  • What are the top competitors in this market and what strategies do they employ to gain shares?
  • What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?
  • What strategies should new companies look to enter this market use to compete effectively?
  • What are the major drivers, restraints and opportunities in the infectious disease diagnostics market?
  • Who are the major players in various countries and what share of the market do they hold?
  • What are the geographical trends and high growth regions/ countries?

Recent partnerships, acquisitions, and expansions have taken place in the global infectious disease diagnostics market

  • What companies have recently merged/acquired and how will these unions affect the competitive landscape of the infectious disease diagnostics market?
  • What companies have created partnerships and how will these partnerships promote a competitive advantage?
  • What is the market positioning/ ranking of various players in the infectious disease diagnostics market?
  • What are the local emerging players in the global infectious disease diagnostics market and how do they compete with the global players?
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare In Vitro Diagnostics Medical Technologies
Download Free Sample
to